The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

General Cancer Screen 63 Tissue Microarray - LS-SCA63

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SCA63
Product Name:	General Cancer Screen 63
Description:	Various organ diseased tissues with stage/grade
Format:	FFPE
Category:	Human Multi-Tumor
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	Yes
Core Diameter:	1 mm
Core Thickness:	5 µm
Cases:	200
Cores:	200
Slides Per Set:	1

LS-SCA63 Tissue Microarray Map

Slide Number 1

LABEL

Sto

Liv

Ova

Ute

Chk

Gin

Lip

Chk

Gin

Max

Lrx

Tng

Lrx

Nsl

Sin

Tng

Man

Sin

Lrx

Sin

Lip

Lrx

Sin

Nsl

Sin

Lrx

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Cheek (Chk); Gingiva (Gin); Larynx (Lrx); Lip (Lip); Liver (Liv); Mandible (Man); Maxilla (Max); Nasal cavity (Nsl); Nasopharynx (Nsl); Ovary (Ova); Ovary, Blood vessel (Ova); Sinus, Maxillary (Sin); Stomach (Sto); Tongue (Tng); Uterus (Ute);

LS-SCA63 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Grade	Tumor Stage	Tumor Differentiation
1	A1	Human	M	59 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	1	II
1	A2	Human	M	67 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	A3	Human	M	66 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3NxM0	1	III
1	A4	Human	M	56 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A5	Human	M	56 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A6	Human	M	61 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A7	Human	M	60 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A8	Human	M	61 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A9	Human	F	60 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A10	Human	M	64 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	1	II
1	A11	Human	F	55 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A12	Human	F	72 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	2	II
1	A13	Human	F	51 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	A14	Human	M	68 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	2	II
1	A15	Human	M	94 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	A16	Human	M	73 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	B1	Human	F	50 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	B2	Human	M	57 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	2	II
1	B3	Human	M	66 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	B4	Human	M	69 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	B5	Human	F	47 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N1M0	3	IB
1	B6	Human	M	60 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	3	IIIA
1	B7	Human	M	64 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N1M0	3	II
1	B8	Human	M	75 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	B9	Human	M	70 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	B10	Human	M	58 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N1M0	2-3	II
1	B11	Human	F	45 y	Stomach (Sto)	Adenocarcinoma	Malignant	T4N0M1	3	IV
1	B12	Human	M	56 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	B13	Human	M	32 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	B14	Human	M	58 y	Stomach (Sto)	Adenocarcinoma, Mucinous	Malignant	T2N0M0	2	IB
1	B15	Human	M	82 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	2	IB
1	B16	Human	M	49 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	C1	Human	M	59 y	Stomach (Sto)	Adenocarcinoma, Mucinous	Malignant	T1N0M0	3	IA
1	C2	Human	F	47 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	C3	Human	F	66 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N0M0	3	IB
1	C4	Human	M	60 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N0M0	3	IB
1	C5	Human	M	65 y	Stomach (Sto)	Adenocarcinoma	Malignant	T4N0M0	3	IIIA
1	C6	Human	M	40 y	Stomach (Sto)	Adenocarcinoma	Malignant	T4N0M0	3	IIIA
1	C7	Human	M	58 y	Stomach (Sto)	Adenocarcinoma, Undifferentiated	Malignant	T2N0M0	4	IB	Undifferentiated
1	C8	Human	F	61 y	Stomach (Sto)	Adenocarcinoma, Undifferentiated	Malignant	T2N0M0	4	IB	Undifferentiated
1	C9	Human	F	48 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	1	III
1	C10	Human	F	62 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	C11	Human	M	68 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	C12	Human	M	62 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T1N0M0	2	I
1	C13	Human	M	45 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	C14	Human	M	65 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	C15	Human	M	43 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	C16	Human	M	49 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	D1	Human	M	49 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	D2	Human	M	46 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	D3	Human	M	40 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	D4	Human	M	35 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	D5	Human	F	65 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	D6	Human	F	64 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	D7	Human	F	49 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	D8	Human	M	70 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	D9	Human	M	46 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	D10	Human	M	58 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	D11	Human	F	52 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	D12	Human	M	40 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	D13	Human	M	56 y	Liver (Liv)	Hepatocellular carcinoma with necrosis	Malignant	T3N0M0	3	III
1	D14	Human	M	42 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T4N0M0	3	IVA
1	D15	Human	F	62 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	3	III
1	D16	Human	F	52 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	E1	Human	M	52 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	3	III
1	E2	Human	M	45 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	1	II
1	E3	Human	M	45 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	2	II
1	E4	Human	M	63 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	3	II
1	E5	Human	M	47 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	3	III
1	E6	Human	F	47 y	Liver (Liv)	Hepatocellular carcinoma with fatty degeneration	Malignant	T3N0M0		III
1	E7	Human	M	35 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	E8	Human	M	41 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	E9	Human	M	35 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	3	II
1	E10	Human	F	68 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	3	II
1	E11	Human	M	46 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	3	III
1	E12	Human	F	69 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	E13	Human	M	38 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	3	III
1	E14	Human	M	64 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	3	II
1	E15	Human	F	46 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	3	III
1	E16	Human	F	55 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	2	III
1	F1	Human	F	46 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1N0M0	2	I
1	F2	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1bN0M0	2	IB
1	F3	Human	F	41 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	1	IA
1	F4	Human	F	26 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	1	IA
1	F5	Human	F	32 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1N0M0		I
1	F6	Human	F	25 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1aN0M0	1	IA
1	F7	Human	F	48 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1N0M0	1	I
1	F8	Human	F	48 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	1	IA
1	F9	Human	F	49 y	Ovary (Ova)	Clear cell carcinoma	Malignant	T1N0M0	1-2	I
1	F10	Human	F	60 y	Ovary (Ova)	Endometrioid adenocarcinoma	Malignant	T2N0M0	2	II
1	F11	Human	F	56 y	Ovary, Blood vessel (Ova)	Adenocarcinoma, Serous with fibrous hyalinosis	Malignant	T1bN0M0		IB
1	F12	Human	F	24 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1aN0M0	1	IA
1	F13	Human	F	73 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1bN0M0	3	IB
1	F14	Human	F	49 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	2	IA
1	F15	Human	F	56 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1bN0M0	3	IB
1	F16	Human	F	66 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T3aN0M0	2	IIIA
1	G1	Human	F	64 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1aN0M0	2	IA
1	G2	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1cN0M0	2	IC
1	G3	Human	F	48 y	Ovary (Ova)	Adenocarcinoma, Mucinous	Malignant	T1aN0M0	3	IA
1	G4	Human	F	69 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T2N0M0	2	II
1	G5	Human	F	55 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1aN0M0	2	IA
1	G6	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	3	IA
1	G7	Human	F	47 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	3	IA
1	G8	Human	F	52 y	Ovary (Ova)	Adenocarcinoma, Serous and papillary	Malignant	T1aN0M0	2	IA
1	G9	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1bN0M0	3	IB
1	G10	Human	F	53 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	2	IA
1	G11	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T3N0M0	3	III
1	G12	Human	F	58 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	3	IA
1	G13	Human	F	57 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1cN0M0	3	IC
1	G14	Human	F	45 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	3	IA
1	G15	Human	F	55 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1aN0M0	3	IA
1	G16	Human	F	56 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T2N0M0	3	II
1	H1	Human	F	54 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T2N0M0	3	II
1	H2	Human	F	48 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T3cN1M1	3	IV
1	H3	Human	F	50 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T3N1M0	3	IIIC
1	H4	Human	F	39 y	Ovary (Ova)	Adenocarcinoma, Serous with necrosis	Malignant	T2N0M0	3	II
1	H5	Human	F	40 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1N0M0	2	I
1	H6	Human	F	52 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1cN0M0	3	IC
1	H7	Human	F	55 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T1bN0M0	3	IB
1	H8	Human	F	56 y	Ovary (Ova)	Adenocarcinoma, Serous	Malignant	T2N0M0	3	II
1	H9	Human	F	40 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2N0M0	1	II
1	H10	Human	F	61 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	1	IC
1	H11	Human	F	40 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	1	IB
1	H12	Human	F	51 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1aN0M0	1	IA
1	H13	Human	F	65 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1aN0M0	2	IA
1	H14	Human	F	62 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	1	IC
1	H15	Human	F	57 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	H16	Human	F	65 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2bN0M0	2	IIB
1	I1	Human	F	50 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2	IB
1	I2	Human	F	50 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2	IB
1	I3	Human	F	53 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2	IB
1	I4	Human	F	40 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2aN0M0	2	IIA
1	I5	Human	F	51 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2	IB
1	I6	Human	F	35 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2bN0M0	2	IIB
1	I7	Human	F	58 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	I8	Human	F	61 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2	IB
1	I9	Human	F	62 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2	IB
1	I10	Human	F	30 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	I11	Human	F	65 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	I12	Human	F	40 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2	IB
1	I13	Human	F	68 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	I14	Human	F	55 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	I15	Human	F	57 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	I16	Human	F	52 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2	IB
1	J1	Human	F	64 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	2-3	IB
1	J2	Human	F	59 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	J3	Human	F	52 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	J4	Human	F	50 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2bN0M0	2	IIB
1	J5	Human	F	56 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1N0M0	2	I
1	J6	Human	F	57 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	2	IC
1	J7	Human	F	45 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	3	IB
1	J8	Human	F	48 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2N0M0	2	IIA
1	J9	Human	F	60 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	3	IC
1	J10	Human	F	64 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	3	IB
1	J11	Human	F	57 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	3	IC
1	J12	Human	F	53 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1cN0M0	3	IC
1	J13	Human	F	56 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T2aN0M0	3	IIA
1	J14	Human	F	47 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T3aN0M0	3	IIIA
1	J15	Human	F	55 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1bN0M0	3	IB
1	J16	Human	F	63 y	Uterus (Ute)	Endometrioid adenocarcinoma	Malignant	T1aN0M0	3	IA
1	K1	Human	M	77 y	Cheek (Chk)	Squamous cell carcinoma	Malignant	T3N0M0	1	III
1	K2	Human	M	40 y	Gingiva (Gin)	Squamous cell carcinoma	Malignant	T4N0M0	1	IV
1	K3	Human	M	81 y	Lip (Lip)	Squamous cell carcinoma	Malignant	T2N0M0	1	II
1	K4	Human	F	51 y	Cheek (Chk)	Squamous cell carcinoma	Malignant	T4N0M0	1	IV
1	K5	Human	M	52 y	Gingiva (Gin)	Squamous cell carcinoma	Malignant	T1N0M0	1	I
1	K6	Human	M	49 y	Maxilla (Max)	Squamous cell carcinoma	Malignant	T4N0M0	1	IV
1	K7	Human	M	54 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	1	III
1	K8	Human	M	56 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T4N0M0	1	IV
1	K9	Human	M	58 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	1	III
1	K10	Human	M	65 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T2N0M0	2	II
1	K11	Human	M	66 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T2N0M0	1	II
1	K12	Human	M	61 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	1	III
1	K13	Human	M	60 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T4N0M0	1	IV
1	K14	Human	M	50 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T4N0M0	2	IV
1	K15	Human	M	61 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	2	III
1	K16	Human	M	60 y	Tongue (Tng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	L1	Human	M	60 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	2	III
1	L2	Human	M	47 y	Nasal cavity (Nsl)	Squamous cell carcinoma	Malignant	T2N0M0	2	II
1	L3	Human	M	42 y	Nasal cavity (Nsl)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	L4	Human	M	62 y	Sinus, Maxillary (Sin)	Squamous cell carcinoma with necrosis	Malignant	T4N0M0		IV
1	L5	Human	M	70 y	Sinus, Maxillary (Sin)	Squamous cell carcinoma	Malignant	T2N0M0	2	II
1	L6	Human	M	57 y	Tongue (Tng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	L7	Human	F	61 y	Mandible (Man)	Squamous cell carcinoma	Malignant	T2N0M0	2	II
1	L8	Human	M	75 y	Sinus, Maxillary (Sin)	Squamous cell carcinoma	Malignant	T4N0M0	2	IV
1	L9	Human	M	64 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T4N1M0	2	IV
1	L10	Human	M	52 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	2	III
1	L11	Human	M	60 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	3	III
1	L12	Human	M	43 y	Sinus, Maxillary (Sin)	Squamous cell carcinoma	Malignant	T2N0M0	3	II
1	L13	Human	M	57 y	Lip (Lip)	Squamous cell carcinoma	Malignant	T1N0M0		I
1	L14	Human	M	57 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T4N0M0	3	IV
1	L15	Human	F	47 y	Sinus, Maxillary (Sin)	Squamous cell carcinoma	Malignant	T1N0M0	3	I
1	L16	Human	M	43 y	Nasal cavity (Nsl)	Squamous cell carcinoma	Malignant	T3N0M0	3	III
1	M1	Human	F	56 y	Nasopharynx (Nsl)	Squamous cell carcinoma	Malignant	T2N0M0	3	II
1	M2	Human	M	56 y	Nasopharynx (Nsl)	Squamous cell carcinoma	Malignant	T2N0M0	3	II
1	M3	Human	M	62 y	Nasopharynx (Nsl)	Squamous cell carcinoma	Malignant	T1N0M0	3	I
1	M4	Human	F	36 y	Sinus, Maxillary (Sin)	Squamous cell carcinoma	Malignant	T2N0M0	3	II
1	M5	Human	M	52 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	3	III
1	M6	Human	M	46 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	3	III
1	M7	Human	M	64 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T2N0M0	3	II
1	M8	Human	M	63 y	Larynx (Lrx)	Squamous cell carcinoma	Malignant	T3N0M0	3	III

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.